Medicine-Infectious Diseases

administers grant

1/2 REPRIEVE Extension for Trial Completion
1/2 REPRIEVE Extension for Trial Completion
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
A participant-derived xenograft mouse model to study T-cell-mediated viral control and mRNA vaccine strategies
A randomized study to evaluate antibody response to an additional dose of SARS-CoV-2 vaccination with and without immunosuppression reduction in kidney and liver transplant recipients
ACTG LOC: PF A5379 - Y3 Protocol co-Chair (1560 G YC257)
ACTG LOC: PF A5391 – Y2 Protocol co-Chair (1560)
ACTG LOC: PF Chair A5386 - Y3 Protocol co-Chair (1560 G YC266)
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections, ACTG LOC: PF A5357 - Y3 Protocol Vice Chair (1560)
Aging with HIV: Novel Biomarkers of Inflammation and Morbidity
Antibacterial Resistance Leadership Group (ARLG)
Bacteria and Host in TB Transmission
Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae
Bacterial and Host Heterogeneity in TB latency, persistence and progression
CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation
Cefiderocol in the Treatment of Stenotrophomas Maltophilia Pneumonia
Cerebrospinal Fluid in PASC: A Window into the COVID Mind
Characterization of Non-subtype B HIV-1 Reservoirs and its Association with Longitudinal Clinical Outcomes
Characterizing non-direct antiviral functions of bNAbs
Clonal Hematopoeisis in HIV and Aging
Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia
Deciphering Mechanisms of HIV Latency Reversal in Perinatal Infection
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
Defining and then Maximizing the Footprint of CTL Selection on HIV Integration Site Landscapes to Optimize Cure Strategies
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
Defining the mechanism of coma in cerebral malaria
Delivery of Addiction Treatment for Medicaid Enrollees with Serious Injection-Related Infections
Determining the interplay of MAIT cells and the translocated microbiome in HIV-induced neuroinflammation
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
Enhancing Susceptibility of HIV Reservoirs to CTL Through a Discovery to Translational Approach
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
Epigenetic dysregulation of inflammation linked to longitudinal cardiac toxicity in perinatal HIV infection
Epigenetics of HIV, Aging, and Sleep Deficiency
HIV Prevention Trials Network (HPTN 083 FHI360 - WCM)
HIV Prevention Trials Network (HPTN 083 FHI360 - WCM)
HIV Vaccine Research and Development (INHCC)
HOPE - HIV Obstruction by Programmed Epigenetics
HOPE Supplement: Understanding HIV Diversity to Accelerate Transcriptional Silencing
HOPE in Action Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients (RTB-009)
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer''s from HIV-Associated Cognitive Dysfunction
Harnessing single cell epigenome-wide profiling of myeloid cells to compare and contrast Alzheimer''s from HIV-associated cognitive dysfunction
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
Immunologic control of HIV-1 through combination bNAbs and biologics
Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence
Impact of Microbial Dysbiosis on MAIT Cell Tissue Repair Program after Acute HIV Infection
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment
Intrinsic and non-cell autonomous regulation of the SMC epigenetic clock
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk
Investigating the Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) for Measures of Cardiovascular Disease Risk and Neurocognitive Impairment in People Living with HIV-1
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG)
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - A5391
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7803
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) [UM1AI068636] - PF CRS 7804
Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1
Measurement of HIV Proviral Reservoir Using Intact Proviral DNA Assay
Mechanisms of CTL Resistance in HIV Reservoirs
Mental Health and Cognition in HIV Infection in Rakai Uganda
Metabolic determinants of Mtb virulence, vulnerability and variation - Core A
Metabolic determinants of Mtb virulence, vulnerability and variation - Core B
Metabolic determinants of Mtb virulence, vulnerability and variation - Project 2
Metabolic determinants of Mtb virulence, vulnerability and variation - Project 3
Metabolomics to identify synergistic TB targets
Moderate to Severe COVID-19 Breakthrough Infections After COVID-19 Vaccination and Predictors in Immunocompromised Renal Transplant Recipients
NK cell memory development in HIV acute infection and vaccination
Novel approaches for relating genetic variation in endogenous retroviruses to function and disease
Omics for TB: Response to Infection and Treatment
Oral HPV Research Among Latin Americans Living with HIV (ORAL) - H²
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Innovative Dosing Schedules of AmBisome for Treatment of Experimental Invasive Pulmonary Aspergillosis: Establishing a Preclinical Foundation for Improved Patient Care and Outcome
Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events
REACH: Research Enterprise to Advance a Cure for HIV
RECOVER-NEURO: A Platform Protocol for Evaluation of Interventions for Cognitive Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
Relationship between methamphetamine use, viral reservoir dynamics and clinical progression in treated HIV infection
Research Training in Infectious Diseases
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
Single-Cell Analysis of HIV-1 Production and Transmission
TBDR Mediated Cefiderocol Resistance in Psuedomonas
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
Targeting HIV reservoirs in the CNS with CAR/CXCR5 T cells for the long-term remission of HIV.
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV
The Role of Transposable Elements in Healthy Aging and in Alzheimer''s Disease
The Transmission Biology of Mycobacterium Tuberculosis
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary Bottleneck
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
Tri-I Training Program in Metabolomics
UJMT LAUNCH: Training the next generation of leaders in global health research
Understanding Immune Evasion by HIV-1 Repliclones
Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium - -Expanding Diversity for Global Equity (EDGE) (VUMC 99377)
Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit
Weill Cornell Medicine Physician-Scientist Academy

VIVO Weill Cornell Medical College

Medicine-Infectious Diseases Academic Department

Research

administers grant